MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
attributable to common...
-$2,772,564
(73.19%↑ Y/Y)
Net loss
-$1,796,195
(81.22%↑ Y/Y)
Preferred stock dividends
$976,369
(25.60%↑ Y/Y)
Interest and dividend
income
$57,575
(172.25%↑ Y/Y)
Change in fair value of
derivatives liabilities
$19,000
Loss before income
tax
-$1,796,195
(81.22%↑ Y/Y)
Total other
(income)/expense
$76,428
(101.23%↑ Y/Y)
Change in fair value of
marketable securities
-$147
Loss from operations
-$1,872,623
(44.43%↑ Y/Y)
Administrative expenses
$894,297
(-12.35%↓ Y/Y)
Research and development
expenses
$873,472
(117.77%↑ Y/Y)
Stock based
compensation expenses
$104,854
(-76.15%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
TNF Pharmaceuticals, Inc. (TNFA)
TNF Pharmaceuticals, Inc. (TNFA)